Your session is about to expire
← Back to Search
HOPE Intervention for COVID-19
N/A
Waitlist Available
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 time request during the 4-week study
Awards & highlights
No Placebo-Only Group
Summary
This trial will assess whether a peer-led online support community can improve behavioral health outcomes related to COVID-19.
Eligible Conditions
- COVID-19 Vaccination
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 time request during the 4-week study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 time request during the 4-week study
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Requests for a COVID-19 Vaccine Resource Sheet
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: HOPE InterventionExperimental Treatment1 Intervention
HOPE peer-led intervention
Group II: ControlActive Control1 Intervention
Control group- online community without peer leaders
Find a Location
Who is running the clinical trial?
University of California, IrvineLead Sponsor
560 Previous Clinical Trials
1,929,882 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You use social media and online communities more than twice a week.You have a friend request and group invite from our Facebook social media page.I'm sorry, please provide the criterion you would like me to rewrite.You must be between the ages of 18 and 30.You do not have medical conditions or other circumstances preventing you from receiving a COVID-19 vaccine.
Research Study Groups:
This trial has the following groups:- Group 1: HOPE Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
COVID-19 Vaccination Patient Testimony for trial: Trial Name: NCT04376515 — N/A
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger